Elite Pharmaceuticals (ELTP) Return on Sales [ROS] (2010 - 2026)
Elite Pharmaceuticals (ELTP) posted Return on Sales [ROS] of 23.27% for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 30.69 percentage points from 53.96% a year earlier and down 1.73 percentage points from the prior quarter.
Elite Pharmaceuticals (ELTP) Return on Sales [ROS] (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Elite Pharmaceuticals was 24.78%, down 10.72 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it came in at 32.99%, up 9.67 percentage points from FY2025.
- Annual Return on Sales [ROS] has increased for three consecutive fiscal years, with a five-year change of +24.70 percentage points (FY2021 to FY2026).
- In prior fiscal years, Elite Pharmaceuticals' Return on Sales [ROS] was 23.32% in FY2025 (+4.27 pp), 19.05% in FY2024 (+8.29 pp), 10.76% in FY2023 (-4.95 pp) and 15.72% in FY2022 (+7.43 pp).
- Quarterly Return on Sales [ROS] has run from a low of -4.48% in fiscal Q4 2023 to a high of 53.96% in fiscal Q1 2026 over five years.
- On a year-over-year basis, Return on Sales [ROS] increased in five of the last eight quarters, with an average year-over-year change of +2.72 percentage points.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was fiscal Q4 2022, with a gain of 35.39 percentage points; the weakest was fiscal Q1 2027, with a drop of 30.69 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior fiscal quarters was 25.00% (Q4 2026), 28.53% (Q3 2026) and 22.61% (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | 28.37% |
| 10 | Elite Pharmaceuticals | 261.23 Mn | 142.90 Mn | 13.51 Mn | 23.27% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.27% |
| Mar 31, 2026 | 25.00% |
| Dec 31, 2025 | 28.53% |
| Sep 30, 2025 | 22.61% |
| Jun 30, 2025 | 53.96% |
| Mar 31, 2025 | 34.86% |
| Dec 31, 2024 | 7.64% |
| Sep 30, 2024 | 18.46% |
| Jun 30, 2024 | 20.55% |
| Mar 31, 2024 | 20.77% |
| Dec 31, 2023 | 22.73% |
| Sep 30, 2023 | 13.60% |
| Jun 30, 2023 | 17.84% |
| Mar 31, 2023 | -4.48% |
| Dec 31, 2022 | 21.18% |
| Sep 30, 2022 | 12.59% |
| Jun 30, 2022 | 13.33% |
| Mar 31, 2022 | 11.10% |
| Dec 31, 2021 | 20.40% |
| Sep 30, 2021 | 16.62% |
Elite Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();